Abstract
This chapter will begin with providing a brief overview of the history of clinical epidemiology and describe its relation with evidence basedmedicine. Clinical epidemiology differs from classical epidemiology in that clinical epidemiology supports other basic medical sciences such as biochemistry, anatomy and physiology because it facilitates their application in research through formulation of sound clinical research methods and, thus, puts these disciplines into clinical context. Therefore, clinical epidemiology goes beyond clinical trials. We will describe this concept in the following paragraphs (see Sect. 8.1.1 through 8.1.3). The following sections include case scenarios that facilitate the introduction of the key concepts about developing clinical questions, using diagnostic tests, evaluating therapy, appraising systematic reviews, developing guidelines and making clinical decisions.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
- Relative Risk Reduction
- Absolute Risk Reduction
- Clinical Epidemiology
- Posttest Probability
- Target Disorder
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
ACC (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. J Am Coll Cardiol 38:1231–1266
Albers G, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE (2001) Antithrombotic therapy in atrial fibrillation. Chest 119:194S–206S
American Urological Association (2000) Prostate-specific antigen (PSA) best practice policy. Oncology: 267–286
Antithrombotic Trialists’ Collaboration (2002) Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71–86
Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC (1992) A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 268:240–248
Arora N, McHorney C (2000) Patient preferences for medical decision making: who really wants to participate? Med Care 38:335–341
Atkins D, Best D, Briss P, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour R, Haugh M, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O’Connell D, Oxman A, Phillips B, Schünemann H, Tan-Torres Edejer T, Varonen H, Vist G, Williams J, Zaza S (2004) Grading evidence and formulating recommendations. BMJ (in press)
Balk EM, Bonis PA, Moskowitz H, Schmid CH, Ioannidis JP, Wang C, Lau J (2002) Correlation of quality measures with estimates of treatment effect in meta analyses of randomized controlled trials. [comment]. JAMA 287(22):2973–2982
Barry MJ (2002) Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. Online 136(2):127–135
Bergner M, Bobbitt R, Carter W, Gilson B (1981) The Sickness Impact Profile: Development and final revision of a health status measure. Med Care 19:787–805
Bernardo JM, Adrian FM (1994) Bayesian theory. Smith Wiley, Chichester
Berry DA (1996) Statistics: A Bayesian perspective. Duxbury Press, Wadworth
Briss P, Zaza S, Pappaioanou M, Feilding J, Wright-de Aguero L, Truman BI, Hopkins DP, Mullen PD, Thompson RS, Woolf SH, Carande-Kulis VG, Anderson L, Hinman AR, MdQueen DV, Teutsch SM, Harris JR, The Task Force on Community Preventive Services (2000) Developing an evidence-based guide to community preventive services-methods. Am J Prev Med 18:35–43
Brook RH, Ware J, Davies-Avery A, Stewart A, Donald C, Williams KN, Johnston SA (1979) Overview of adult health status measures fielded in Rand’s health insurance study. Med Care 17(Suppl 7):1–131
Bucher HC, Weinbacher M, Gyr K (1994) Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 309(6957):761–764
Canadian (1979) Task Force on the Periodic Health Examination. The periodic health examination. CMAJ 121:1193–1254
Chang S, Fine R, Siegel D, Chesney M, Black D, Hulley S (1991) The impact of diuretic therapy on reported sexual function. Arch Intern Med 151:2402–2408
Charles C, Gafni A, Whelan T (1999a) Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 49(5):651–661
Charles C, Whelan T, Gafni A (1999b) What do we mean by partnership in making decisions about treatment? BMJ 319(7212):780–782
Cook DJ G G, Laupacis A, Sackett DL (1992) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest (102):305S–11S
CURE-Investigators (2001) Effects of Clopidogrel in addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segmen Elevation. N Engl J Med 345:494–502
Degner L, Kristjanson L, Bowman D, Sloan J, Carriere K, O’Neil J, Bilodeau B, Watson P, Mueller B (1997) Information needs and decisional preferences in women with breast cancer. JAMA 277:1485–1492
Devereaux PJ, Anderson DR, Gardner MJ, Putnam W, Flowerdew GJ, Brownell BF, Nagpal S, Cox JL (2001) Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 323(7323):1218–1222
Deyo R, Diehl A, Rosenthal M (1986) How many days of bed rest for acute low back pain? a randomized clinical trial. N Engl J Med 315:1064–1070
Diamond GA (1999) The wizard of odds: Bayes theorem and diagnostic testing. Mayo Clin Proc 74(11):1179–1182
Diamond GA, Forrester JS (1979) Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 300(24):1350–1358
Diamond GA, Forrester JS, Hirsch M, Staniloff HM, Vas R, Berman DS, Swan HJ (1980) Application of conditional probability analysis to the clinical diagnosis of coronary artery disease. J Clin Invest 65(5):1210–1221
Diamond GA, Hirsch M, Forrester JS, Staniloff HM, Vas R, Halpern SW, Swan HJ (1981) Application of information theory to clinical diagnostic testing: the electrocardiographic stress test. Circulation 63:915–921
Dolan JG, Bordley DR, Mushlim AI (1986) An evaluation of clinicians’ subjective prior probability estimates. Med Decis Making 6:216–223
Edwards A, Elwyn G (1999) How should effectiveness of risk communication to aid patients’ decisions be judged? A review of the literature. [comment]. Med Dec Making 19(4):428–434
Edwards A, Elwyn G (2001) Evidence-based patient choice. Inevitable or impossible? Oxford University Press, New York
Edwards A, Elwyn G, Stott N (1999) Communicating risk reductions. Researchers should present results with both relative and absolute risks. BMJ 318(7183):603; author reply 603–604
Egger M, Davey Smith G, Altman D (2000) Meta-analysis in context. In: Egger M, Davey Smith G, Altman DG (eds) Systematic reviews in health care. BMJ Books, London
Emanuel E, Emanuel L (1992) Four models of the physician-patient relationship. JAMA 267:2221–2226
Evidence-Based-Medicine-Working-Group (1992) Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 268:2420–2425
Fagan T (1975) Nomogram for Bayes theorem. N Engl J Med 293:257
Feinstein A (1968) Clinical epidemiology I. The population experiments of nature and of man in human illness. Ann Intern Med 69:807–820
Ferrini R, Woolf SH (1998) American College of Preventive Medicine Practice Policy: screening for prostate cancer in American men. Am J Prev Med 15:81–84
Fletcher RH, Fletcher SW, Wagner EH (1996) Clinical epidemiology: The essentials, 3rd edn. Williams and Wilkins, Baltimore
Freemantle N, Mason J, Eccles M (1999) Deriving Treatment Recommendations from Evidence within Randomized Trials: The Role and Limitation of Meta-Analysis. Int J Technol Assess Health Care 15(2):304–315
Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C (2003) Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 289:2554–2559
Frost M, Bonomi A, Capelleri J, Schünemann H, Moynihan T, Aaronson N (2003) Applying quality of life data formally and systematically into clinical practice. Clin Ther 25:D10
García Rodríguez L, Hernández-Díaz S, deAbajo FJ (2001) Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studies. Br J Clin Pharmacol 52:563–571
Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, Goldman L (2002) Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med 346(23):1800–1806
Glass RD (1996) Diagnosis: A brief introduction. Oxford University Press, Melbourne
Goldstein R, Gort E, Guyatt GH, Stubbing D, Avendano M (1994) Prospective randomized controlled trial of respiratory rehabilitation. Lancet 344:1394–1397
Greenfield S, Kaplan SH, Ware JE, Jr., Yano EM, Frank HJ (1988) Patients’ participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med 3(5):448–457
Guyatt GH (1991) Evidence-based medicine. ACP J Club 114:A–16
Guyatt GH (2002a) Introduction. In: Guyatt GH, Rennie D (eds) Users’ guide to the medical literature: A manual for evidence-based clinical practice. AMA Press, Chicago
Guyatt GH (2002b) Preface. In: Guyatt GH, Rennie D (eds) Users’ guide to the medical literature: A manual for evidence-based clinical practice. AMA Press, Chicago
Guyatt GH, Rennie D (2002) Users’ guide to the medical literature: A manual for evidence-based clinical practice. AMA Press, Chicago
Guyatt GH, Bombardier C, Tugwell P (1986) Measuring disease-specific quality-of-life in clinical trials. CMAJ 134:889–895
Guyatt GH, Walter S, Norman G (1987) Measuring change over time: assessing the usefulness of evaluative instruments. J Chronic Dis 40:171–178
Guyatt GH, Zanten SVV, Feeny D, Patrick D (1989) Measuring quality of life in clinical trials: a taxonomy and review. CMAJ 140:1441–1447
Guyatt GH, Patterson C, Ali M, Singer J, Levine M, Turpie I, Meyer R (1990) Diagnosis of iron-deficiency anemia in the elderly. Am J Med 88(3):205–209
Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C (1992) Laboratory diagnosis of iron-deficiency anemia: an overview. [erratum appears in J Gen Intern Med 1992 Jul–Aug;7 (4):423]. J Gen Intern Med 7(2):145–153
Guyatt GH, Sackett D, Sinclair JC, Hayward R, Cook DJ, Cook RJ (1995) Users’ guides to the medical literature IX. A method for grading health care recommendations. Evidence-based medicine working group. JAMA 274:1800–1804
Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS (1999) Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 52:187–192
Guyatt GH, Meade MO, Jaeschke RZ, Cook DJ, Haynes RB (2000) Practitioners of evidence based care. Not all clinicians need to appraise evidence from scratch but all need some skills. BMJ 320(7240):954–955
Guyatt GH, Schünemann H, Cook D, Pauker S, Sinclair J, Bucher H, Jaeschke R (2001) Grades of Recommendation for Antithrombotic Agents. Chest 119:3S–7S
Guyatt GH, Sinclair J, Cook D, Jaeschke R, Schünemann H (2002a) Moving from evidence to action. Grading recommendations — a qualitative approach. In: Guyatt GH, Rennie D (eds) Users’ guides to the medical literature: A manual for evidence-based clinical practice. AMA Press, Chicago
Guyatt GH, Hayward RS, Richardson WS, Green I, Wilson MC, Sinclair J, Cook D, Glasziou P, Detsky A, Bass E (2002b) Moving from evidence to action. In: Guyatt GH, Rennie D (eds) Users’ guide to the medical literature: A manual for evidence-based clinical practice. AMA Press, Chicago
Guyatt GH, Devereaux P, Montori V, Schünemann H, Bhandari M (2004a) Putting the patient first: In our practice, and in our use of language. Evidence Based Medicine 9:6–7
Guyatt GH, Schünemann H, Cook D, Jaeschke R, Pauker S (2004b) Applying the grades of recommendation for antithrombotic and thrombolytic agents. Chest (in press)
Harbour R, Miller J (2001) A new system for grading recommendations in evidence based guidelines. BMJ 323:334–336
Harris R, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D, for the Methods Work Group, Third U.S. Preventive Services Task Force (2001) Current methods of the U.S. Preventive Services Task Force: a review of the process. Am J Prev Med 20(3S):21–35
Haynes RB, Devereaux PJ, Guyatt GH (2002) Clinical expertise in the era of evidence-based medicine and patient choice. ACP J Club 136: A11
Hernandez JL, Riancho JA, Matorras P, Gonzalez-Macias J (2003) Clinical evaluation for cancer in patients with involuntary weight loss without specific symptoms. Am J Med 114(8):631–637
Hill SA, Devereaux PJ, Griffith L, Opie J, McQueen MJ, Panju A, Stanton E, Guyatt GH (2003) Can Troponin I measurement predict short term serious cardiac outcomes in patients presenting to the emergency department with possible acute coronary syndrome. Can J Emerg Med (in press)
Holmes-Rovner M, Llewellyn-Thomas H, Entwistle V, Coulter A, O’Connor A, Rovner DR (2001) Patient choice modules for summaries of clinical effectiveness: a proposal. BMJ 322(7287):664–667
http://www.guidelines.gov/ Accessed March 14, 2004
Hunt S, McKenna S, McEwen J, Backett E, Williams J, Papp E (1980) A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 34:281–286
Jaeschke R, Singer J, Guyatt GH (1991) Using quality-of-life measures to elucidate mechanism of action. CMAJ 144:35–39
Ladenheim ML, Kotler TS, Pollock BH, Berman DS, Diamond GA (1987) Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. Am J Cardiol 59(4):270–277
Laupacis A, Sackett D, Roberts RS (1988) An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 318:1728–1733
Laupacis A, Wong C, Churchill D (1991) The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. Control Clin Trials 12:168S–179S
Ledley RS, Lusted LB (1959) Reasoning foundations of medical diagnosis: symbolic logic, probability, and value theory aid our understanding of how physicians reason. Science 130:9–21
Levine MN, Gafni A, Markham B, MacFarlane D (1992) A bedside decision instrument to elicit a patient’s preference concerning adjuvant chemotherapy for breast cancer. [comment]. Ann Intern Med 117(1):53–58
Liang M, Larson M, Cullen K, Schwartz J (1985) Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 28:542–547
Lubsen J, Kirwan B (2002) Combined endpoints: can we use them? Stat Med 21:2959–2970
MacKenzie M, Charlson M (1986) Standards for the use of ordinal scales in clinical trials. BMJ 292:40–43
Mahler D, Rosiello R, Harver A, Lentine T, McGovern J, Daubenspeck J (1987) Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis 135:1229–1233
McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG (2003) Clinical prediction rules. In: Guyatt GH, Rennie D (eds) Users’ guides to the medical literature: A manual for evidence-based clinical practice. AMA Press, Chicago
McKibbon A, Hunt D, Richardson SW, Hayward R, Wilson M, Jaeschke R, Haynes RB, Wyer P, Craig J, Guyatt GH (2002) Finding the evidence. In: Guyatt GH, Rennie D (eds) Users’ guides to the medical literature: A manual for evidence-based clinical practice. AMA Press, Chicago
Meier MA, Al-Badr WH, Cooper JV, Kline-Rogers EM, Smith DE, Eagle KA, Mehta RH (2002) The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med 162(14):1585–1589
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352(9128):609–613
National-Guideline-Clearing-House (2004) (http://www.guideline.gov/) Accessed March 14, 2004
CNEP (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19):2486–2497
O’Connor A (2001) Using patient decision aids to promote evidence-based decision making. ACP J Club 135(1):A11–A12
O’Connor AM, Legare F, Stacey D (2003) Risk communication in practice: the contribution of decision aids. BMJ 327:736–740
O’Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, Tait V, Tetroe J, Fiset V, Barry M, Jones J (2004) Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews 1
Olsson G, Lubsen J, Van Es G, Rehnqvist N (1986) Quality-of-life after myocardial infarction: effect of long term metoprolol on mortality and morbidity. BMJ 292:1491–1493
Osoba D, Aaronson N, Till J (1991) A practical guide for selecting quality-of-life measures in clinical trials and practice. In: Osoba D (ed) Effect of cancer on quality-of-life. CRC Press, Boston
Ott C, Sivarajan E, Newton K, Almes MJ, Bruce RA, Bergner M, Gilson BS (1983) A controlled randomized study of early cardiac rehabilitation: the sickness impact profile as an assessment tool. Heart Lung 12:162–170
Oxman A, Guyatt GH (1993) The science of reviewing research. Ann NY Acad Sci 703:125–133:discussion 133–134
Oxman A, Guyatt GH, Cook D, Montori V (2002) Summarizing the evidence. In: Guyatt GH, Rennie D (eds) Users’ guide to the medical literature: A manual for evidence-based clinical practice. AMA Press, Chicago
Oxman AD, Sackett DL, Guyatt GH (1993) Users’ guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA 270(17):2093–2095
Parkerson G, Gehlback S, Wagner E, Sherman A, Clapp N, Muhlbaier L (1981) The Duke-UNC Health Profile: an adult health status instrument for primary care. Med Care 19:806–828
Paul J (1938) Clinical epidemiology. J Clin Invest 17:539–541
Petitti D (1994) Meta-analysis, decision analysis and cost-effectiveness analysis. Oxford University Press, Oxford
PIOPED-Investigators (1990) Value of ventilation/perfusion scan in acute pulmonary embolism. Results of the Prospective Investigation of Pulmonary Embolism (PIOPED). JAMA 263:2753–2759
Protheroe J, Fahey T, Montgomery AA, Peters TJ (2000) The impact of patients’ preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. BMJ 320(7246):1380–1384
Richardson WS (2002) Five uneasy pieces about pre-test probability. J Gen Intern Med 17(11):882–883
Richardson WS, Wilson MC, Nishikawa J, Hayward RS (1995) The well-built clinical question: a key to evidence-based decisions. ACP J Club 123(3):A12–A13
Richardson WS, Wilson MC, Williams JW, Jr., Moyer VA, Naylor CD (2003) Clinical Manifestation of Disease. In: Guyatt GH, Rennie D (eds) Users’ guide to the medical literature: A manual for evidence-based clinical practice. AMA Press, Chicago
Sackett D (1969) Clinical epidemiology. Am J Epidemiol 89:125–128
Sackett D (1986) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Arch Int Med 146:464–465
Sackett D (2002) Clinical Epidemiology: what, who, and whither. J Clin Epidemiol 55:1161–1166
Sackett D, Winkelstein W (1967) The relationship between cigarette usage and aortic atherosclerosis. Am J Epidemiol 86:264–270
Sackett D, Chambers L, MacPherson A, Goldsmith C, McAuley R (1977) The development and application of indices of health: general methods and a summary of results. Am J Public Health 67:423–428
Sackett D, Haynes RB, Guyatt GH, Tugwell P (1991) Clinical epidemiology: a basic science for clinical medicine. Little, Brown, Boston, pp 5–17
Sackett D, Straus S, Richardson W, Rosenberg W, Haynes RB (2000) Evidence-based medicine. Churchill Livingston, Toronto, p 166
Schünemann HJ, Best D, Vist G, Oxman AD, for The GRADE Working Group (2003) Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ 169(7):677–680
Schünemann H, Munger H, Brower S, O’Donnell M, Crowther M, Cook D, Guyatt GH (2004) Developing evidence-based guidelines for the ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest in press
Shekelle PG, Woolf SH, Eccles M, Grimshaw J (1999) Clinical guidelines: developing guidelines. BMJ 318(7183):593–596
Smith D, Baker G, Davies G, Dewey M, Chadwick. D (1993) Outcomes of add-on treatment with Lamotrigine in partial epilepsy. Epilepsia 34:312–322
Smith R, Cokkinides V, Eyre H (2003) American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 53:27–43
Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L, Benjamin EJ, Levy D (2002) Incidence and Prognosis of Syncope. N Engl J Med 347(12):878–885
Sox HC, Blatt MA, Higgins MC, Marton KL (1988) Medical decision making. Butterworths, Boston
Stewart M (1995) Effective physician-patient communication and health outcomes: a review. CMAJ 152:1423–1433
Stiggelbout A, Kiebert G (1997) A role for the sick role. Patient preferences regarding information and participation in clinical decision-making. CMAJ 157:383–389
Strull W, Lo B, Charles G (1984) Do patients want to participate in medical decision making? JAMA 252:2990–2994
Symons MJ, Moore DT (2002) Hazard rate ratio and prospective epidemiological studies. J Clin Epidemiol 55(9):893–899
Szabo E, Moody H, Hamilton T, Ang C, Kovithavongs C, Kjellstrand C (1997) Choice of treatment improves quality of life. A study on patients undergoing dialysis. Arch Intern Med 157:1352–1356
Tandon P, Stander H, Jr. RS (1989) Analysis of quality of life data from a randomized, placebo controlled heart-failure trial. J Clin Epidemiol 42:955–962
Tarlov A, Ware J, Greenfield S, Nelson E, Perrin E, Zubkoff M (1989) The medical outcomes study. JAMA 262:925–930
The CAPRICORN Investigators (2001) Effects of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357:1385–1390
Thomson R, Parkin D, Eccles M, Sudlow M, Robinson A (2000) Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet 355:956–962
Torrance G (1986) Measurement of health state utilities for economic appraisal. J Health Econ:1–30
Tugwell P, Bombardier C, Buchanan W, Goldsmith C, Grace E, Bennett K, Williams J, Egger M, Alarcon GS, Guttadauria M (1990) Methotrexate in Rheumatoid Arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med 150:59–62
USPSTF (2002) Screening for prostate cancer: recommendations and rationale. Ann Intern Med 137:915–916
van Walraven C, Hart R, Singer D (2002) Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 288:2441–2448
Ware J, Kozinski M, Bayliss M, McHorney CA, Rogers WH, Raczak A (1995) Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results of the Medical Outcomes Study. Med Care 33:AS264–AS279
Ware J, Sherbourne C (1992) The MOS 36-item short-form health survey (SF-36). Med Care 30:473–483
Weil J, Colin-Jones D, Langman M, Lawson D. Logan R, Murphy M, Rawlins M, Vessey M, Wainright P (1995) rophylactic aspirin and risk of peptic ulcer bleeding. BMJ 310:827–830
Whelan T, Sawka C, Levine M, Gafni A, Reyno L, Willan A, Julian J, Dent S, AbuZahra H, Chouinard E, Tozer R, Pritchard K, Bodendorfer I (2003) Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. [comment]. J Nat Cancer Inst 95(8):581–587
Wiebe S, Guyatt GH, Weaver B, Matijevic S, Sidwell C (2003) Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 56(1):52–60
Weiss N (1996) Clinical epidemiology: the study of the outcome of illness, 2nd edn. Oxford University Press, Oxford
Woolf SH (1994) An organized analytic framework for practice guideline development: using the analytic logic as a guide for reviewing evidence, developing recommendations, and explaining the rationale. In: McCormick KA, Moore S, Siegel RA (eds) Methodology perspectives. US Department of Health and Human Services, Agency for Health Care Policy and Research, Washington, DC
Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 318(7182):527–530
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schünemann, H.J., Guyatt, G.H. (2005). Clinical Epidemiology. In: Ahrens, W., Pigeot, I. (eds) Handbook of Epidemiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-26577-1_30
Download citation
DOI: https://doi.org/10.1007/978-3-540-26577-1_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00566-7
Online ISBN: 978-3-540-26577-1
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)